(Q33730677)

29 July 2017

1 reference

title

Is the societal perspective in cost-effectiveness analysis useful for decision makers? (English)

1 reference

29 July 2017

L B Russell

1

1 reference

29 July 2017

D G Fryback

series ordinal

2

1 reference

29 July 2017

F A Sonnenberg

series ordinal

3

1 reference

29 July 2017

publication date

1 September 1999

1 reference

The Joint Commission journal on quality improvement

29 July 2017

published in

1 reference

29 July 2017

volume

25

1 reference

29 July 2017

issue

9

1 reference

29 July 2017

page(s)

447-454

1 reference

The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930458-8

7 January 2021

Recommendations of the Panel on Cost-effectiveness in Health and Medicine

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930458-8

7 January 2021

Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930458-8

7 January 2021

Myocardial revascularization for chronic stable angina. Analysis of the role of percutaneous transluminal coronary angioplasty based on data available in 1989.

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930458-8

7 January 2021

Methods of cost-effectiveness analysis in the assessment of new drugs for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930458-8

7 January 2021

Cost-effectiveness of a routine varicella vaccination program for US children

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930458-8

7 January 2021

Cost-effectiveness and cost-benefit analyses in the medical literature. Are the methods being used correctly?

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930458-8

7 January 2021

Screening for mild thyroid failure at the periodic health examination: a decision and cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930458-8

7 January 2021

A cost-effectiveness analysis of total hip arthroplasty for osteoarthritis of the hip.

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930458-8

7 January 2021

School-based screening for tuberculous infection. A cost-benefit analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930458-8

7 January 2021

Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research

1 reference

https://api.crossref.org/works/10.1016%2FS1070-3241%2816%2930458-8

7 January 2021

10.1016/S1070-3241(16)30458-8

Identifiers

DOI

1 reference

29 July 2017

1 reference